It sounds like you're asking about tarlatamab-dlle (brand name Imdelltra) — a newer immunotherapy drug being used in lung cancer treatment. It's an exciting development worth knowing about!
Here's how it works:
- It's a bispecific antibody, meaning it can bind to two targets at once
- It attaches to both lung cancer cells Show Full Answer
It sounds like you're asking about tarlatamab-dlle (brand name Imdelltra) — a newer immunotherapy drug being used in lung cancer treatment. It's an exciting development worth knowing about!
Here's how it works:
- It's a bispecific antibody, meaning it can bind to two targets at once
- It attaches to both lung cancer cells and immune cells (T cells)
- By bringing them closer together, it helps the immune system recognize and attack the cancer more effectively
It has received FDA accelerated approval specifically for extensive-stage small cell lung cancer (SCLC). As with any cancer treatment, there are potential risks and side effects to be aware of. It's really important to have a detailed conversation with your oncologist to find out if this treatment could be appropriate for your specific situation, stage, and type of lung cancer.
Clinical decisions are always best made with your care team who knows your full medical history. 💙
June 29
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
